|
Initial Whole-Brain Radiation for Brain Metastases Questioned
Mercredi 24 Septembre 2008 - 08:41 - 2 mois, 1 semaine depuis - Presse spécialisée - Medscape hematology oncology Radiation oncologists documenting the deleterious effects of whole-brain radiation on neurocognitive functioning question whether it should remain a standard initial therapy for brain metastases. Medscape Medical News |
|
A New Way to Train and Support the World's Health Workers
Lundi 22 Septembre 2008 - 05:52 - 2 mois, 1 semaine depuis - Presse spécialisée - Medscape hematology oncology Erica Frank, MD, MPH, Professor, Canada Research Chair, University of British Columbia, and Founder, Executive Director, Health Sciences Online, describes an exciting new online science resource. The Medscape Journal of Medicine |
|
Have Genome-wide Association Studies Made Major Contributions?
Vendredi 19 Septembre 2008 - 12:52 - 2 mois, 2 semaines depuis - Presse spécialisée - Medscape hematology oncology In his video blog, Dr. Eric Topol reacts to a story published in Science Times by underscoring the value of genome-wide association studies. Medscape Pathology |
|
Novel Agents Potentially Beneficial in Recurrent Ovarian Cancer
Vendredi 19 Septembre 2008 - 11:00 - 2 mois, 2 semaines depuis - Presse spécialisée - Medscape hematology oncology Two novel agents exhibited antitumor activity in women with recurrent ovarian cancer and hold promise as effective second-line treatments Medscape Medical News |
|
The Role of Cytoreductive/Debulking Surgery in Ovarian Cancer
Vendredi 19 Septembre 2008 - 09:00 - 2 mois, 2 semaines depuis - Presse spécialisée - Medscape hematology oncology Aggressive surgical cytoreduction is becoming more common for patients with ovarian cancer, and when performed, increases median survival. How, when, and why debulking should be used are discussed. Journal of the National Comprehensive Cancer Network |
|
Company, Investigator Disagree on Reporting of Epoetin Alfa Trial in Stroke
Vendredi 19 Septembre 2008 - 08:12 - 2 mois, 2 semaines depuis - Presse spécialisée - Medscape hematology oncology Ortho Biotech announced that preliminary data from a trial of epoetin alfa in stroke patients show higher mortality among treated patients than those on placebo and that it had informed the FDA. The lead investigator of the trial, though, says the statement is inaccurate as it stands and that the increase in mortality was limited to patients who received both tissue plasminogen activator and epoetin alfa. Medscape Medical News |
|
Economic Credentialing: Terminating Staff Privileges for Investing in a Competing Hospital
Vendredi 19 Septembre 2008 - 05:42 - 2 mois, 2 semaines depuis - Presse spécialisée - Medscape hematology oncology Jack R. Bierig, AB, JD, Partner, Sidley Austin, LLP, Chicago, Illinois; Lecturer in Law, University of Chicago, Chicago, Illinois, teaches us about a serious hospital-medical staff conflict. The Medscape Journal of Medicine |
|
PEG-Liposomal Doxorubicin Useful for Maintenance Therapy in Metastatic Breast Cancer
Jeudi 18 Septembre 2008 - 14:29 - 2 mois, 2 semaines depuis - Presse spécialisée - Medscape hematology oncology A pegylated-liposomal doxorubicin formulation offers a low-toxicity option for maintenance therapy in metastatic breast cancer, say Spanish researchers. Medscape Medical News |
|
New Studies Improve Evidence Base for Colorectal Cancer Screening
Jeudi 18 Septembre 2008 - 14:00 - 2 mois, 2 semaines depuis - Presse spécialisée - Medscape hematology oncology Use of computed tomographic colonography as a screening tool and the use of a 5-year or longer rescreening period after a normal colonoscopy examination have been strengthened by 2 new, large studies. Medscape Medical News |
|
Gardasil Approval Expanded to Prevention of HPV-Related Vulvar, Vaginal Cancer
Jeudi 18 Septembre 2008 - 14:00 - 2 mois, 2 semaines depuis - Presse spécialisée - Medscape hematology oncology The FDA has approved a quadrivalent recombinant vaccine for the prevention of vaginal and vulvar cancer caused by human papillomavirus types 16 and 18 in girls and women aged 9 to 26 years. Medscape Medical News |
< 1 – 2 – 3 – 4 – 5 – 6 – 7 – 8 – 9 – 10 – 11 – 12 – 13 – 14 – 15 – 16 – 17 – 18 – 19 – 20 – 21 – 22 – 23 – 24 – 25 >
Actus fournies par : Medscape Hematology-Oncology Headlines